Literature DB >> 6392351

Identification of Brevibacterium from clinical sources.

D G Pitcher, H Malnick.   

Abstract

Coryneform bacteria of the genus Brevibacterium occur on the normal skin surface, but reports of human infection with this genus are lacking. A number of cultures of coryneform bacteria sent to the National Collection of Type Cultures for identification have been identified as Brevibacterium spp on the basis of their cell wall composition and ability to produce methane-thiol from L-methionine. We describe a rapid method for the detection of methane-thiol and confirmatory tests which differentiate Brevibacterium from morphologically similar genera.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6392351      PMCID: PMC499044          DOI: 10.1136/jcp.37.12.1395

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  9 in total

1.  Production of S-Methylthioacetate by Brevibacterium linens.

Authors:  A Cuer; G Dauphin; A Kergomard; J P Dumont; J Adda
Journal:  Appl Environ Microbiol       Date:  1979-08       Impact factor: 4.792

2.  Methanethiol production by coryneform bacteria: strains from dairy and human skin sources and Brevibacterium linens.

Authors:  M E Sharpe; B A Law; B A Phillips; D G Pitcher
Journal:  J Gen Microbiol       Date:  1977-08

3.  Rapid identification of cell wall components as a guide to the classification of aerobic coryneform bacteria from human skin.

Authors:  D G Pitcher
Journal:  J Med Microbiol       Date:  1977-11       Impact factor: 2.472

4.  Use of litmus milk agar for presumptive identification of cutaneous propionibacteria.

Authors:  G F Webster; K J McGinley
Journal:  J Clin Microbiol       Date:  1977-06       Impact factor: 5.948

5.  Corynebacterium spp in human disease.

Authors:  J E Hine; L R Hill; S P Lapage
Journal:  Lancet       Date:  1978-08-12       Impact factor: 79.321

6.  Antibiotic production by cutaneous Brevibacterium sp.

Authors:  A M Al-Admawy; W C Noble
Journal:  J Appl Bacteriol       Date:  1981-12

7.  Brevibacterium sp. from poultry.

Authors:  K Mohan
Journal:  Antonie Van Leeuwenhoek       Date:  1981-12       Impact factor: 2.271

8.  Detection of volatile sulfide-producing bacteria isolated from poultry-processing plants.

Authors:  T A McMeekin; P A Gibbs; J T Patterson
Journal:  Appl Environ Microbiol       Date:  1978-06       Impact factor: 4.792

9.  Corynebacterium bovis as a cause of human disease.

Authors:  J A Vale; G W Scott
Journal:  Lancet       Date:  1977-10-01       Impact factor: 79.321

  9 in total
  11 in total

1.  Characterization of Brevibacterium spp. from clinical specimens.

Authors:  E Gruner; G E Pfyffer; A von Graevenitz
Journal:  J Clin Microbiol       Date:  1993-06       Impact factor: 5.948

2.  Brevibacterium casei sepsis in an 18-year-old female with AIDS.

Authors:  P Brazzola; R Zbinden; C Rudin; U B Schaad; U Heininger
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

Review 3.  Clinical microbiology of coryneform bacteria.

Authors:  G Funke; A von Graevenitz; J E Clarridge; K A Bernard
Journal:  Clin Microbiol Rev       Date:  1997-01       Impact factor: 26.132

4.  Brevibacterium species as a cause of osteomyelitis in a neonate.

Authors:  B Neumeister; T Mandel; E Gruner; G E Pfyffer
Journal:  Infection       Date:  1993 May-Jun       Impact factor: 3.553

5.  Differentiation of Brevibacterium spp. encountered in clinical specimens.

Authors:  G Funke; A Carlotti
Journal:  J Clin Microbiol       Date:  1994-07       Impact factor: 5.948

6.  Recurrent bacteremia due to Brevibacterium casei in an immunocompromised patient.

Authors:  R R Reinert; N Schnitzler; G Haase; R Lütticken; U Fabry; K P Schaal; G Funke
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-12       Impact factor: 3.267

7.  Bacteremia caused by Brevibacterium species in an immunocompromised patient.

Authors:  S S Kaukoranta-Tolvanen; A Sivonen; A A Kostiala; P Hormila; M Vaara
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-09       Impact factor: 3.267

8.  Human infections caused by Brevibacterium casei, formerly CDC groups B-1 and B-3.

Authors:  E Gruner; A G Steigerwalt; D G Hollis; R S Weyant; R E Weaver; C W Moss; M Daneshvar; J M Brown; D J Brenner
Journal:  J Clin Microbiol       Date:  1994-06       Impact factor: 5.948

9.  Evaluation of API Coryne in comparison with conventional methods for identifying coryneform bacteria.

Authors:  J Freney; M T Duperron; C Courtier; W Hansen; F Allard; J M Boeufgras; D Monget; J Fleurette
Journal:  J Clin Microbiol       Date:  1991-01       Impact factor: 5.948

10.  Association between baseline abundance of Peptoniphilus, a Gram-positive anaerobic coccus, and wound healing outcomes of DFUs.

Authors:  Kyung R Min; Adriana Galvis; Katherine L Baquerizo Nole; Rohita Sinha; Jennifer Clarke; Robert S Kirsner; Dragana Ajdic
Journal:  PLoS One       Date:  2020-01-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.